Indeed, reduced P-gp expression and compromised P-gp function at the BBB have been implicated in the pathogenesis of neurodegenerative conditions including Parkinson’s disease [65,115,116], Alzheimer’s disease [25,117] and multiple sclerosis [118], as well as with ageing [119,120,121]. The gene discussed is PGP; the disease is Alzheimer disease.